Surgical treatment of hypertrophic cardiomyopathy

Sameh M. Said, Hartzell V Schaff

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Hypertrophic cardiomyopathy (HCM) is a unique primary myocardial disease characterized by unexplained left ventricular hypertrophy in absence of another etiology. One of the key features is the presence of systolic anterior motion of the anterior leaflet of the mitral valve which causes left ventricular outflow tract obstruction with various degrees of mitral valve regurgitation. Surgical septal myectomy is the preferred treatment of choice if medical treatment is unsuccessful or intolerable. We summarize in this review the available treatment options for HCM.

Original languageEnglish (US)
Pages (from-to)300-309
Number of pages10
JournalSeminars in Thoracic and Cardiovascular Surgery
Volume25
Issue number4
DOIs
StatePublished - 2013

Fingerprint

Hypertrophic Cardiomyopathy
Ventricular Outflow Obstruction
Mitral Valve Insufficiency
Left Ventricular Hypertrophy
Cardiomyopathies
Mitral Valve

Keywords

  • Apical myectomy
  • Hypertrophic cardiomyopathy
  • Septal myectomy

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Surgery
  • Pulmonary and Respiratory Medicine
  • Medicine(all)

Cite this

Surgical treatment of hypertrophic cardiomyopathy. / Said, Sameh M.; Schaff, Hartzell V.

In: Seminars in Thoracic and Cardiovascular Surgery, Vol. 25, No. 4, 2013, p. 300-309.

Research output: Contribution to journalArticle

@article{32032d6bc6f94684a46ee6af8e8aec73,
title = "Surgical treatment of hypertrophic cardiomyopathy",
abstract = "Hypertrophic cardiomyopathy (HCM) is a unique primary myocardial disease characterized by unexplained left ventricular hypertrophy in absence of another etiology. One of the key features is the presence of systolic anterior motion of the anterior leaflet of the mitral valve which causes left ventricular outflow tract obstruction with various degrees of mitral valve regurgitation. Surgical septal myectomy is the preferred treatment of choice if medical treatment is unsuccessful or intolerable. We summarize in this review the available treatment options for HCM.",
keywords = "Apical myectomy, Hypertrophic cardiomyopathy, Septal myectomy",
author = "Said, {Sameh M.} and Schaff, {Hartzell V}",
year = "2013",
doi = "10.1053/j.semtcvs.2014.01.001",
language = "English (US)",
volume = "25",
pages = "300--309",
journal = "Seminars in Thoracic and Cardiovascular Surgery",
issn = "1043-0679",
publisher = "W.B. Saunders Ltd",
number = "4",

}

TY - JOUR

T1 - Surgical treatment of hypertrophic cardiomyopathy

AU - Said, Sameh M.

AU - Schaff, Hartzell V

PY - 2013

Y1 - 2013

N2 - Hypertrophic cardiomyopathy (HCM) is a unique primary myocardial disease characterized by unexplained left ventricular hypertrophy in absence of another etiology. One of the key features is the presence of systolic anterior motion of the anterior leaflet of the mitral valve which causes left ventricular outflow tract obstruction with various degrees of mitral valve regurgitation. Surgical septal myectomy is the preferred treatment of choice if medical treatment is unsuccessful or intolerable. We summarize in this review the available treatment options for HCM.

AB - Hypertrophic cardiomyopathy (HCM) is a unique primary myocardial disease characterized by unexplained left ventricular hypertrophy in absence of another etiology. One of the key features is the presence of systolic anterior motion of the anterior leaflet of the mitral valve which causes left ventricular outflow tract obstruction with various degrees of mitral valve regurgitation. Surgical septal myectomy is the preferred treatment of choice if medical treatment is unsuccessful or intolerable. We summarize in this review the available treatment options for HCM.

KW - Apical myectomy

KW - Hypertrophic cardiomyopathy

KW - Septal myectomy

UR - http://www.scopus.com/inward/record.url?scp=84896450910&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84896450910&partnerID=8YFLogxK

U2 - 10.1053/j.semtcvs.2014.01.001

DO - 10.1053/j.semtcvs.2014.01.001

M3 - Article

C2 - 24673959

AN - SCOPUS:84896450910

VL - 25

SP - 300

EP - 309

JO - Seminars in Thoracic and Cardiovascular Surgery

JF - Seminars in Thoracic and Cardiovascular Surgery

SN - 1043-0679

IS - 4

ER -